Back to search
Sjögrens Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Sjögrens Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Sjögrens Disease trials you may qualify forThe purpose of this study is to demonstrate the comparability of ianalumab exposure following the sub-cutaneous (s.c.) administration of one injection of 300 mg…
Primary objective of the study is to evaluate the effect of abiprubart on an established systemic disease activity measure for Sjögren's Disease.